elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33626106-1B57538E-E9C4-4DEC-9CD3-60435E1AC953
Q33626106-1B57538E-E9C4-4DEC-9CD3-60435E1AC953
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33626106-1B57538E-E9C4-4DEC-9CD3-60435E1AC953
A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab.
P407
Q33626106-1B57538E-E9C4-4DEC-9CD3-60435E1AC953
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33626106-1B57538E-E9C4-4DEC-9CD3-60435E1AC953
rank
NormalRank
type
BestRank
Statement
P407
English